Bionano Genomics Inc. (NASDAQ: BNGO) stock closed at 1.51 per share at the end of the most recent trading day (a -6.79% change compared to the prior day closing price) with a volume of 5.44M shares and market capitalization of 437.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 97 people. Bionano Genomics Inc. CEO is Mark Adamchak.

The one-year performance of Bionano Genomics Inc. stock is -78.46%, while year-to-date (YTD) performance is -49.5%. BNGO stock has a five-year performance of %. Its 52-week range is between 1.16 and 8.2, which gives BNGO stock a 52-week price range ratio of 4.97%

Bionano Genomics Inc. currently has a PE ratio of -4.90, a price-to-book (PB) ratio of 1.51, a price-to-sale (PS) ratio of 21.33, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -25.98%, a ROC of -26.31% and a ROE of -28.28%. The company’s profit margin is -%, its EBITDA margin is -451.50%, and its revenue ttm is $20.51 Million , which makes it $0.07 revenue per share.

Of the last four earnings reports from Bionano Genomics Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Bionano Genomics Inc.’s next earnings report date is 03rd Aug 2022.

The consensus rating of Wall Street analysts for Bionano Genomics Inc. is Strong Buy (1), with a target price of $8.25, which is +446.36% compared to the current price. The earnings rating for Bionano Genomics Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bionano Genomics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bionano Genomics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 26.03, ATR14 : 0.14, CCI20 : 28.35, Chaikin Money Flow : -0.02, MACD : -0.05, Money Flow Index : 64.47, ROC : -4.71, RSI : 52.65, STOCH (14,3) : 66.67, STOCH RSI : 1.00, UO : 44.44, Williams %R : -33.33), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bionano Genomics Inc. in the last 12-months were: Christopher Stewart (Option Excercise at a value of $46 200), David L. Barker (Buy at a value of $16 000), R. Erik Holmlin (Buy at a value of $20 037)